Cardiovascular and Renal Drugs Advisory Committee; Cancellation

---
identifier: "/us/fr/05-6331"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Cardiovascular and Renal Drugs Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "05-6331"
section_name: "Cardiovascular and Renal Drugs Advisory Committee; Cancellation"
positive_law: false
currency: "2005-03-31"
last_updated: "2005-03-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-6331"
document_type: "notice"
publication_date: "2005-03-31"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "70 FR 16506"
fr_volume: 70
fr_action: "Notice."
---


#  Cardiovascular and Renal Drugs Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is canceling the meeting of the Cardiovascular and Renal Drugs Advisory Committee scheduled for April 5, 2005. This meeting was announced in the *Federal Register* of March 9, 2005 (70 FR 11678).

**FOR FURTHER INFORMATION CONTACT:**

Cathy A. Groupe, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) code 3014512533.

Dated: March 24, 2005.

Sheila Dearybury Walcoff,

Associate Commissioner for External Relations.